Ataxia Charlevoix-Saguenay Foundation
In 2006, the Foundation was created and funded the first research to be undertaken since the identification of the Ataxia gene in 2000. It was crucial to begin research in order to discover a treatment for Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS).
Since its creation, the Foundation has funded several research projects related to this neurological disorder. The Foundation is a charitable organization and is supported entirely by private donations and volunteers who support the cause.

Research Objectives
The main research objective of the Ataxia Charlevoix-Saguenay Foundation is to develop a treatment for ARSACS. Every year the Foundation financed several research projects in Canada and abroad. The efforts of the Foundation are concentrated currently in three main research areas:
Financing of several promising research projects with reearchers that are experts in this field.
Forming partnerships with other organizations and pharmaceutical companies to further the understanding of this disease and conduct independent research.
Conducting clinical trials
Scientific Advisory Board
All applications for research grants are evaluated by the Scientific Advisory Board of the Ataxia of Charlevoix-Saguenay Foundation according to specific criteria.
Research Grants
To further encourage and accelerate the development of a treatment for ARSACS, the Ataxia Charlevoix-Saguenay Foundation provides grants and opportunities to researchers.
This year, the call for proposals of the Ataxia of Charlevoix-Saguenay Foundation is jointly supported by the “Richardson Research Fund” to fund ARSACS research projects.
As part of this funding offer, the Ataxia Charlevoix-Saguenay Foundation in collaboration with the “Richardson Research Fund” offers up to a maximum of $100,000 CAD per project and up to $25,000 CAD per project to support start-up initiatives (Seed Grant).
Both types of grants are awarded for a 12-month period, with the possibility of renewal. For more information and to apply : ARSACS Call for Proposals and Application Form.
ARSACS Research Projects
2026-2027
The Foundation gratefully acknowledges the generous support of the Richardson Trust Fund and Action for ARSACS Foundation USA (AFA) in helping fund the 2026–2027 ARSACS research projects.
Dr. Galatolo’s ARSACS Research Report
Research report "Retinal pigment epithelium (RPE) cell system to uncover the molecular mechanisms of ARSACS-related retinal defects" - Dr. Daniel Galatolo (IRCCS Fondazione Stella Maris, Pisa, Italy). . This project was funded by the ARSACS Foundation in 2022-2023.
Recherche du Dr Daniele Gataloto
Rapport du projet de recherche " Retinal pigment epithelium (RPE) cell system to uncover the molecular mechanisms of ARSACS - related retinal defects" du Dr Daniele Galatolo ( IRCCS Fondazione Stella Maris, Pise, Italie). Ce projet a été financé par la Fondation en...
Recherche des Drs Herrera, Fernandes et Adams
Rapport du projet de recherche "Towards glial-targeted therapies of ARSACS" de l'équipe de chercheurs Drs Herrera , Fernandes (Université de Lisbonne ) et Dre Adams ( Université Bilkent en Turquie). Ce projet a été financé par la Fondation en 2022-2023.
Drs Herrera/Fernandes/Adams’s Research Report
"Towards glial-targeted therapies of ARSACS" final research report from the research team of Drs. Herrera and Fernandes (University of Lisbon) and Dr. Adams ( Bilkent University in Turkey). This project was funded by the Foundation in 2022-2023.
Interactors of sacsin’s DNAJ domain identify function in organellar transport and membrane composition relevant to ARSACS pathogenesis
Interactors of sacsin’s DNAJ domain identify function in organellar transport and membrane composition relevant to ARSACS pathogenesis – Dr. Benoit Gentil. Dr. Gentil’s article on the functions of sacsin published in preprint in BioRvix..
Deux amis relèvent un défi pour la cause ARSACS
En cette période des Fêtes, voici une vidéo d'un bel exemple d'amitié, de générosité et de soutien de la communauté à la cause ARSACS. L'automne dernier, Gabriel et Olivier, deux amis d'enfance, ont réussi leur Défi Charlevoix- Saguenay et ont amassé 15 000$ pour la...
Friends coming together for a cause
During this Holiday Season, here is an inspiring video of friendship, generosity and community support for the ARSACS cause. Last Fall, Gabriel and Olivier , two childhood friends, took up the Défi Charlevoix- Saguenay and raised $15, 000 for ARSACS research....
Dr. Desnoyers joins the Foundation’s Board
The Ataxia Charlevoix-Saguenay Foundation is pleased to announce the newest member of its Board of Directors. As vice-president at Neuron23, Dr. Luc Desnoyers is leading the biomarker and diagnostics efforts to move programs from the late-stage research to clinical...
Dr Desnoyers se joint au Conseil de la Fondation
La Fondation de l’Ataxie Charlevoix-Saguenay est heureuse d'annoncer l'arrivée du Dr Luc Desnoyers à son conseil d'administration. En tant que vice-président chez Neuron23, Dr Desnoyers dirige les efforts en matière de biomarqueurs et de diagnostics pour faire passer...
Faits saillants du Symposium sur l’ARSACS
Faits saillants du 7ième Symposium International sur l'ARSACS tenu en octobre. Sincères remerciements au Dr Justin Wolter pour la production de ce résumé.
Major highlights of the 7th ARSACS Symposium
Major highlights of the ARSACS Symposium held in October. Thank you to Dr Justin Wolter for his dedication in providing this summary.
1,1 M$ pour l’ARSACS lors du Diner des Producteurs !
Les fonds collectés sont essentiels pour financer les projets de recherche, préparer un essai clinique et ainsi nous rapprocher d’un traitement pour les personnes atteintes de l’ARSACS. Nous tenons à remercier sincèrement nos donateurs, partenaires et dévoués...
Diner des Producteurs raised $1.1 M for ARSACS!
The funds raised will play a crucial role in funding research projects and paving the way for a clinical trial. Therefore, bringing us one step closer to providing hope and relief to those affected by ARSACS. We want to express our deepest gratitude to our donors,...
Rapport d’étape du Dr Chapple
Rapport d'étape pour le projet de recherche “Molecular rewiring in cellular models of ARSACS ” du Dr Paul Chapple, Barts and London Queen Mary’s School of Medicine, London, UK. Rapport de la première année du projet financé par la Fondation. (rapport en version...
Dr. Chapple’s research progress report
“Molecular rewiring in cellular models of ARSACS ” research progress report from Dr. Paul Chapple, Barts and London Queen Mary’s School of Medicine, London, UK. Report for the first year of the project financed by the Foundation.
Un don pour la recherche sur l’ARSACS en ce “mardi je donne”
Ce "mardi je donne" à la recherche sur l'ARSACS, une cause qui revêt une immense importance pour les personnes touchées par cette maladie génétique rare. Votre contribution, quel que soit son montant, peut jouer un rôle crucial dans le financement des recherches qui...
Give for ARSACS Research this Giving Tuesday!
This Giving Tuesday, we are rallying support for ARSACS research—a cause that holds immense significance for those affected by this rare genetic condition. Your contribution, no matter the amount, can play a crucial role in funding research that brings us closer to a...
Gene Therapy – what is it?
As part of the TREAT ARCA project, a webinar was held in September 2023 to demystify the world of gene therapy!. It was designed to break down the complexities of gene therapy into easy-to-follow concepts. Discover its potential to shape the future of medicine. Gene...
Thérapie Génétique – de quoi s’agit-il?
Dans le cadre du projet TREAT ARCA, voici la traduction d’une présentation éclairante qui a eu lieu en septembre 2023 et qui démystifie le monde de la thérapie génique! Cette présentation a été conçue pour décomposer les complexités de la thérapie génique en concepts...
Symposium International ARSACS – Un grand succès!
200 inscriptions au symposium, un événement scientifique sur la recherche sur l'ARSACS. Les discussions ont été dynamiques et ont mis en lumière les dernières avancées de la recherche. Le symposium a définitivement favorisé une approche collaborative. La participation...
ARSACS International Symposium – A Great Success!
Opening remarks by Sonia Gobeil, cofounder of the Foundation
Molecular rewiring in cellular models of ARSACS – by Dr. Paul Chapple, Barts and London Queen Mary’s School of Medicine
Molecular rewiring in cellular models of ARSACS – by Dr. Paul Chapple, Barts and London Queen Mary’s School of Medicine
Encore 2 semaines pour soumettre votre projet de recherche
Date limite : 23 novembre 2023. L' Organizzatione Di Volontariato ARSACS , en collaboration avec Téléthon, finance des projets de recherche « d'amorçage » pour une durée de 12 mois avec un budget maximum de 50 000 €. Plus de détails.
2 more weeks to submit your research project
Deadline: November 23, 2023 to submit your project. The ARSACS Organizzatione Di Volontariato (ARSACS ODV) in collaboration with Telethon is financing "seed" research projects for a 12-month period with a maximum budget of €50,000. More details.
Me Jean Groleau is appointed Chair of the Board of Directors at Catalis
"I am pleased to have the opportunity to ensure that in every major decision the organization makes, the needs of patients and care givers will be considered. As the parent of children with a rare disease and co-founder and president of a foundation dedicated to...
Me Groleau nommé au poste de président du conseil de Catalis
"Je suis heureux de pouvoir veiller à ce que les besoins des patient·e·s et des personnes procheaidantes soient pris en compte dans chacune des grandes décisions de l’organisation. En tant que parent d’enfants atteints d’une maladie rare, et cofondateur et président...
OVD s’associe à Téléthon pour financer la recherche sur l’ARSACS
L' Organizzatione Di Volontariato ARSACS , en collaboration avec Téléthon, est heureuse d'annoncer une opportunité pour les chercheurs de travailler sur l'ARSACS. L'initiative vise à financer des projets de recherche « d'amorçage » pour une durée de 12 mois avec un...
OVD partner with Telethon to fund ARSACS research
The ARSACS Organizzatione Di Volontariato (ARSACS ODV) in collaboration with Telethon is pleased to announce an opportunity for researchers to work on ARSACS . The initiative aims to finance "seed" research projects for a 12-month period with a maximum budget of...
Inscrivez-vous maintenant au 7e Symposium international sur l’ARSACS
Joignez -vous à nous les 19 et 20 octobre au 7e Symposium international sur l'ARSACS. Une belle opportunité de découvrir les dernières avancées de la recherche ARSACS. Un événement en personne et virtuel. C'est gratuit et ouvert à tous. Inscription
Register now to the 7th International Symposium on ARSACS.
Join us on October 19 and 20 at the 7th International Symposium on ARSACS. A great opportunity to learn about the latest advancements in ARSACS research. It will be an in-person and virtual event. It is free and open to all. Registration
An investment of $700,000 in ARSACS research
The Ataxia Charlevoix Saguenay Foundation is pleased to announce the funding ofsix innovative research projects in 2023-2024. Press Release.
Un investissement de 700 000$ dans la recherche sur l’ARSACS
La Fondation de l’Ataxie Charlevoix- Saguenay est fière d’annoncer qu’elle financera six nouveaux projets de recherche en 2023-2024. Communiqué.
“Elucidating mechanisms underlying motor coordination rescue in a mouse model of ARSACS” – Dre Alanna Watt et Dre Anne McKinney
One of the hallmark features of ARSACS is dysfunction and eventual death of Purkinje cells in the cerebellum, which contributes to ataxia. Strikingly, not all Purkinje cells become ill and die: rather, specific patterns of vulnerability and resilience to cell death...
“Therapeutic Approaches for ARSACS”- Drs Benoit Gentil et Heather Durham
ARSACS is characterised by the lack of sacsin expression, and the formation of intermediate filaments bundles in neurons and fibroblasts derived from skin biopsies. Our strategy over the last years has been aimed at developing a replacement therapy, by peptide and/or...
“A mouse- human single nuclei-RNA seq profiling in ARSACS cerebellun: understanding how alterations i different cell types contribute to neurodegeneration” – Dre Francesca Maltecca
This project aims to evaluate the contribution of the different cerebellar cell types to neurodegeneration in ARSACS. In our recent publication (Del Bondio et al., 2023) we showed that in the ARSACS mouse cerebellum there is increased expression of astrocytic...
“Discovery of new ARSACS modifier genes in the Saguenay founder population” – Dr Simon Girard
L’Ataxie Récessive Spastique Autosomique de Charlevoix-Saguenay (ARSACS) est une maladie neurologique rare et invalidante. On la retrouve avec des prévalences beaucoup plus élevés dans plusieurs régions du monde, notamment au Saguenay-Lac-St-Jean. Cette prévalence...
“Structural Determination of Sacsin” – Dr Walid Houry
Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is a progressive neurodegenerative genetic disorder characterized by an early childhood onset. ARSACS presents with polyneuropathy, with hallmark loss of cerebellar Purkinje neurons, and movement...
“Exploring and treating cognitive dysmetria in the mouse model of ARSACS” – Dr Stefan Strack
The cerebellum is critical for the coordination of movements and thought processes. Indeed, patient suffering from spinocerebellar ataxias including ARSACS commonly display psychiatric and cognitive symptoms. These cognitive and neuropsychiatric symptoms are often...
“Therapeutic Approaches for ARSACS”- Drs. Benoit Gentil and Heather Durham
ARSACS is characterised by the lack of sacsin expression, and the formation of intermediate filaments bundles in neurons and fibroblasts derived from skin biopsies. Our strategy over the last years has been aimed at developing a replacement therapy, by peptide and/or...
“Elucidating mechanisms underlying motor coordination rescue in a mouse model of ARSACS” – Drs. Alanna Watt & Anne McKinney
One of the hallmark features of ARSACS is dysfunction and eventual death of Purkinje cells in the cerebellum, which contributes to ataxia. Strikingly, not all Purkinje cells become ill and die: rather, specific patterns of vulnerability and resilience to cell death...
“A mouse-human single nuclei-RNA seq profiling in ARSACS cerebellum: understanding how alterations in different cell types contribute to neurodegenration” – Dr. Francesca Maltecca
This project aims to evaluate the contribution of the different cerebellar cell types to neurodegeneration in ARSACS. In our recent publication (Del Bondio et al., 2023) we showed that in the ARSACS mouse cerebellum there is increased expression of astrocytic...
“Discovery of new ARSACS modifier genes in the Saguenay founder population” – Dr. Simon Girard
The Autosomal Recessive Spastic Ataxia of Charlevoix Saguenay (ARSACS) is a rare and depilating neurological disease. It is found with much higher prevalences in several regions of the world, notably in Saguenay Lac St jean. This high prevalence is explained by a...
“Structural Determination of Sacsin” – Dr. Walid Houry
Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is a progressive neurodegenerative genetic disorder characterized by an early childhood onset. ARSACS presents with polyneuropathy, with hallmark loss of cerebellar Purkinje neurons, and movement...
“Exploring and treating cognitive dysmetria in the mouse model of ARSACS” – Dr. Stefan Strack
The cerebellum is critical for the coordination of movements and thought processes. Indeed, patient suffering from spinocerebellar ataxias including ARSACS commonly display psychiatric and cognitive symptoms. These cognitive and neuropsychiatric symptoms are often...
Congratulations Gabriel and Olivier !
Gabriel Paquet- Desbiens and Olivier Houde , two childhood friends, accomplished their Défi Charlevoix- Saguenay to help finance research for the Charlevoix- Saguenay Ataxia, from which Gabriel is affected. They covered 143Km by cycling or jogging last weekend. The...
Félicitations Gabriel et Olivier pour votre exploit!
Gabriel Paquet- Desbiens et Olivier Houde, deux amis d'enfance, ont relevé leur défi Charlevoix - Saguenay pour aider à financer la recherche sur l'Ataxie Charlevoix- Saguenay dont est atteint Gabriel. Ils ont parcouru 143 Km à vélo et jogging. La Fondation remercie...
Inscrivez-vous au Symposium International sur l’ARSACS – 19 et 20 octobre 2023 à Montréal
Une occasion unique de vous informer sur les dernières avancées de la recherche sur l’ARSACS et de rencontrer l’équipe de recherche ARSACS. Vous pouvez participer à cet événement scientifique gratuit soit en personne ou encore en ligne. Nouveau cette année, une table...
Still time to register to the ARSACS International Symposium on October 19- 20, 2023
A great opportunity to learn about the latest advancements in ARSACS research and to meet the ARSACS research team. You can attend this free scientific symposium either in-person or on-line. New this year, a panel discussion with ARSACS patients, carers and partners....
“Therapeutic Approaches for ARSACS”- Dr. Benoit Gentil and Dr. Heather Durham
ARSACS is characterised by the lack of sacsin expression and the formation of intermediate filaments bundles in neurons and fibroblasts derived from skin biopsies. Our strategy over the last years has been aimed at developing a replacement therapy, by peptide...
A SACS deletion variant in Great Pyrenees dogs causes autosomal recessive neuronal degeneration
A SACS deletion variant in Great Pyrenees dogs causes autosomal recessive neuronal degeneration – Dr. Kari J. Ekenstedt. Research published in Human Genetics in September, 2023..
“Preclinical studies in the Sacs KO mouse model of ARSACS”- Dr Strack
Rapport d'étape pour le projet de recherche “Preclinical studies in the Sacs KO mouse model of ARSACS” sous la direction du Dr Stefan Strack de l'Université d'Iowa, E.U.
“Preclinical studies in the Sacs KO mouse model of ARSACS”- Dr. Strack
“Preclinical studies in the Sacs KO mouse model of ARSACS”- research project under the leadership of Dr Stefan Strack from University of Iowa, USA
Preclinical studies in the Sacs KO mouse model of ARSACS – by Dr. Stefan Strack, University of Iowa, USA
Preclinical studies in the Sacs KO mouse model of ARSACS – by Dr. Stefan Strack, University of Iowa, USA project funded by the Foundation in 2021-2022
Le Diner des Producteurs - Reservation form
Le Diner des Producteurs 2023 - Réservations
Thank you to Rio Tinto and business entrepreneurs in Saguenay!
As part of a program at improving worker health, Rio Tinto et 3 business companies from Saguenay donate $2,887.50 for ARSACS research. Thank you to the donors and the organizers for their generosity. Photo from L to R, Mr. Etienne Fortin (Rio Tinto), Georges Perron...
“A mitochondrial-targeted antioxidant (MitoQ) improves motorcoordination and reduces Purkinje cell death in a mouse model”
“A mitochondrial-targeted antioxidant (MitoQ) improves motor coordination and reduces Purkinje cell death in a mouse model of ARSACS”– ARSACS research by Drs. Watt and McKinney from McGill published in the Neurobiology of Disease journal in May, 2023. Research funded...
Merci à Rio Tinto et aux entrepreneurs du Saguenay !
Dans le cadre d’un programme à visant à améliorer la santé-sécurité des travailleurs, Rio Tinto et 3 entrepreneurs du Saguenay font un don de 2 887.50$ pour la recherche sur l'ARSACS. Merci aux donateurs et organisateurs pour leur générosité ! Sur la photo, de g-à-dr....
“A mitochondrial-targeted antioxidant improves motor coordination and reduces Purkinje cell death in a mouse model”
“A mitochondrial-targeted antioxidant (MitoQ) improves motor coordination and reduces Purkinje cell death in a mouse model of ARSACS”– recherche sur l'ARSACS des Dres Watt et McKinney de l'Université McGill publiée dans Neurobiology of Disease en mai 2023. La...
Publication de la recherche du Dre Maltecca
Recherche sur l'ARSACS de l'équipe du Dre Maltecca publiée dans JCI insights en mai 2023. “Restoring calcium homeostasis in Purkinje cells arrests neurodegeneration and neuroinflammation in the ARSACS mouse model”
ARSACS research by Dr. Maltecca’s team published
ARSACS research by Dr. Maltecca and her team published in the JCI insights in May, 2023. "Restoring calcium homeostasis in Purkinje cells arrests neurodegeneration and neuroinflammation in the ARSACS mouse model"
Symposium ARSACS 2023 – Inscrivez-vous maintenant
Une occasion unique de s'informer sur les dernières avancées de la recherche sur l'ARSACS. Une réunion satellite accréditée du Congrès mondial de neurologie 2023 (WCN), le Symposium ARSACS aura lieu immédiatement après la clôture du WCN soit les 19 et 20 octobre à...
Register now ! 2023 ARSACS Symposium
Join us for an unique opportunity to learn about the latest advancements in ARSACS research. As an accredited satellite meeting of the 2023 World Congress of Neurology (WCN), the ARSACS Symposium will be held immediately following the WCN on October 19 -20 in...
Unravelling defective trans-synaptic signaling in ARSACS – by Dr. Francesca Maltecca, Ospedale San Raffaele, Milan, Italy
Unravelling defective trans-synaptic signaling in ARSACS – by Dr. Francesca Maltecca, Ospedale San Raffaele, Milan, Italy project funded by the Foundation in 2021-2022
“UNRAVELLING DEFECTIVE TRANS-SYNAPTIC SIGNALING IN ARSACS”- Dre Maltecca
Résumé du rapport d'étape pour le projet “Unravelling defective trans-synaptic signaling in ARSACS” sous la direction du Dre Francesca Maltecca, une recherche financée par la Fondation en 2021-2022.
“UNRAVELLING DEFECTIVE TRANS-SYNAPTIC SIGNALING IN ARSACS”- Dr. F. Maltecca
Summary of the progression report for the project "Unravelling defective trans-synaptic signaling in ARSACS” under the leadership of Dr. Francesca Maltecca, a research funded by the Foundation in 2021-2022.
Restoring calcium homeostasis in Purkinje cells arrests neurodegeneration and neuroinflammation in the ARSACS mouse model
Restoring calcium homeostasis in Purkinje cells arrests neurodegeneration and neuroinflammation in the ARSACS mouse model – Dr. Francesca Maltecca. Research by Dr. Maltecca published in JCI Insights, May 2023..
A mitochondrial-targeted antioxidant (MitoQ) improves motor coordination and reduces Purkinje cell death in a mouse model of ARSACS
A mitochondrial-targeted antioxidant (MitoQ) improves motor coordination and reduces Purkinje cell death in a mouse model of ARSACS – Dr. Alanna Watt, Dr. Anne McKinney. Research from McGill University published in Neurobiology of Disease..
PROSPAX project presented at the ICAR and AGI conferences
The International Congress for Ataxia Research (ICAR) and the Ataxia Global Initiative (AGI) were held between November 1st – 4th 2022 in Dallas, Texas, USA. In order to become ready for clinical trials, it is important that outcomes can measure the progression of...
Projet PROSPAX aux conférences ICAR et AGI
Le Congrès International pour la Recherche sur l'Ataxie (ICAR) et Ataxia Global Initiative (AGI) ont eu lieu du 1er au 4 novembre 2022 à Dallas, Texas, États-Unis. Afin de se préparer pour des essais cliniques, il est important que les résultats puissent mesurer la...
“Unraveling the role of glial cells in ARSACS Rationale”
Rapport d'étape du projet de recherche "Unraveling the role of glial cells in ARSACS Rationale" des Drs Federico Herrera (Université de Lisbonne), Adelaide Fernandes (Université de Lisbonne) et Michelle Adams (Université Bilken, Turquie). Ce projet est fiancé par la...
“Unraveling the role of glial cells in ARSACS Rationale”
Mid term report for the research project by Drs. Federico Herrera (University of Lisbon), Adelaide Fernandes (University of Lisbon) and Michelle Adams (Bilken University, Turkey). This project is funded by the Foundation in 2022-2023. English version and also in...
Recherche sur l’ARSACS publiée dans Stem Cells International
La recherche sur l'ARSACS du Dr Dupré et de son équipe du CHU de Québec et de l'Université Laval a été publiée dans le Stem Cells International Journal le 15 avril 2023. “In Vitro Characterization of Motor Neurons and Purkinje Cells Differentiated from Induced...
ARSACS research published in Stem Cells International
ARSACS research, conducted by Dr. Dupré and his team from the CHU de Québec and Laval University, was published in the Stem Cells International Journal on April 15, 2023. "In Vitro Characterization of Motor Neurons and Purkinje Cells Differentiated from Induced...
“Creating an open Science Repository of ARSACS hiPSCs” – Rapport de recherche du Dr Dupré
“Creating an Open Science Repository of ARSACS hiPSCs” – rapport préléminaire pour le projet de recherche sous la direction du Dr Nicolas Dupré, recherche financée par la Fondation en 2020-2021.
“Creating an open Science Repository of ARSACS hiPSCs” – Dr. Dupré
"Creating an Open Science Repository of ARSACS hiPSCs" - a report on the progression of the project under the leadership of Dr. Nicolas Dupré, research funded by the Foundation in 2020-2021.
Unraveling the role of glial cells in ARSACS Rationale – by Drs. Federico Herrera, Adelaide Fernandes, and Michelle Adams, University of Lisbon / Bilkent University
Unraveling the role of glial cells in ARSACS Rationale – by Drs. Federico Herrera, Adelaide Fernandes, and Michelle Adams, University of Lisbon / Bilkent University Project funded by the Foundation in 2022-2023
Creating an Open Science Repository of ARSACS hiPSCs – by Dr. Nicolas Dupré, CHU de Québec-Université Laval
Creating an Open Science Repository of ARSACS hiPSCs – by Dr. Nicolas Dupré, CHU de Québec-Université Laval funded by the Foundation in 2020-2021
Effect of neuroprotective molecules dietary supplementation on ARSACS zebrafish model development – by Dr. Valentina Naef, IRCCS Fondazione Stella Maris, Pisa, Italy
Effect of neuroprotective molecules dietary supplementation on ARSACS zebrafish model development – by Dr. Valentina Naef, IRCCS Fondazione Stella Maris, Pisa, Italy . This project was funded by the ARSACS Foundation in 2022-2023
Faits saillants du Congrès International sur la Recherche des Ataxies et d’ Ataxia Global Initiative
Ataxia UK, la National Ataxia Foundation et Friedreich's Ataxia Research Alliance ont organisé le Congrès International sur la Recherche des Ataxies (ICAR) à Dallas, Texas, E. U., l'un des plus grands rassemblements de chercheurs sur l'ataxie jusqu'à ce jour. La...
Highlights from the ICAR and Ataxia Global Initiative Conferences
In November 2022, Ataxia UK, the National Ataxia Foundation (NAF), and the Friedreich’s Ataxia Research Alliance (FARA) co-hosted the International Congress for Ataxia Research (ICAR) in Dallas, Texas, USA, one of the largest gatherings of ataxia researchers to date....
In Vitro Characterization of Motor Neurons and Purkinje Cells Differentiated from Induced Pluripotent Stem Cells Generated from Patients with Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay
In Vitro Characterization of Motor Neurons and Purkinje Cells Differentiated from Induced Pluripotent Stem Cells Generated from Patients with Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay – Dr. Nicolas Dupré. Research article by Dr. Nicolas Dupré published...
Publication de la recherche du Dr Chapple utilisant la technologie IA
La recherche du Dr Chapple "AlphaFold predicted structure of the Hsp90-like domains of the neurodegeneration linked protein Sacsin reveals key residues for ATPase activity" a été publiée dans Frontiers in Molecular Biosciences en janvier 2023. L'équipe de chercheurs a...
Dr. Chapple’s research using AI technology published
Dr. Paul Chapple's research article "AlphaFold predicted structure of the Hsp90-like domains of the neurodegeneration linked protein Sacsin reveals key residues for ATPase activity" was published in Frontiers in Molecular Biosciences in January 2023. The research team...
Let’s support Gabriel and Olivier
Gabriel Paquet Desbiens and Olivier Houde launched a huge challenge to raise funds for the Foundation to pursue its mission. These two childhood friends will cycle or run from Baie St-Paul to Ville de la Baie in three days starting September 15. Gabriel is affected by...
Encourageons Gabriel et Olivier
Gabriel Paquet Desbiens et Olivier Houde ont lancé un défi colossal dans le but d'amasser des fonds pour aider la Fondation à poursuivre sa mission. Ces deux amis d'enfance feront, à vélo ou à la course, le trajet Baie St-Paul à Ville de la Baie en trois jours dès le...
Intéressé (e) à vous joindre à l’équipe de chercheurs sur l’ ARSACS?
La Fondation vous invite à soumettre votre projet de recherche. Le financement peut atteindre jusqu’à 100 000$ pour une période de 12 mois avec possibilité de renouvellement. Le comité scientifique de la Fondation évaluera chaque projet. Appel d' offres, Formulaire de...
Interested in joining the ARSACS research team ?
The Foundation is inviting you to send your research proposal. The research grant could be as high as $100,000 for a 12-month period and with possibility for renewal. The Scientific Advisory Board of the Foundation will evaluate each application. Call for Proposal,...
Réservez la date !
Pour plus d'information, visitez le site Web
Save the Date !
For more information, visit the website
Sami Fruits Foundation donates $50,000 for Ataxia Research
As part of the Sami Fruits pour les Petits Foundation 2022 Gala, Mr. Flavio Condo, director of the Foundation, presented on February 8 a $50,000 check to Mrs. Sonia Gobeil from the Ataxia Charlevoix-Saguenay Foundation. This amount will directly contribute to the...
Fondation Sami Fruits fait un don de 50 000$ pour la recherche sur l’Ataxie
Dans le cadre du Gala 2022 de la Fondation Sami Fruits pour les Petits, M. Flavio Condo, directeur de la Fondation, a remis le 8 février dernier un chèque de 50 000$ à Mme Sonia Gobeil de Fondation de l'Ataxie Charlevoix-Saguenay. Cette somme contribuera directement...
“Premiers indices que l’ARSACS pourrait impliquer un métallome altéré”
" Synchrotron Light provides the first clues that ARSACS might involve an altered metallome" selon les résultats de la recherche du Dr Graham George et de son équipe. Ce projet de recherche intitulé “Understanding the role of Metals in ARSACS” a été financé...
“First clues that ARSACS might involve an altered metallome”
“Synchrotron Light provides the first clues that ARSACS might involve an altered metallome” according to the research results of Dr. Graham George and his team. This research project entitled “Understanding the role of Metals in ARSACS” was funded jointly by the...
AlphaFold predicted structure of the Hsp90-like domains of the neurodegeneration linked protein sacsin reveals key residues for ATPase activity
AlphaFold predicted structure of the Hsp90-like domains of the neurodegeneration linked protein sacsin reveals key residues for ATPase activity – Dr. Paul Chapple. Published in Frontiers, January 13, 2023..
1.1M$ pour la recherche sur l’ARSACS – Merci!
Au nom des personnes vivant avec l'ARSACS, de leurs familles et de la Fondation, merci à vous tous pour votre générosité: Monsieur Vincent Chiara, président d’honneur, commanditaires, partenaires, donateurs et bénévoles. C’est grâce à vous que la Fondation peut...
$1.1M raised for ARSACS Research – Thank you !
On behalf of the persons living with ARSACS, their families and the Foundation, thank you to all of you for your generosity : Mr. Vincent Chiara, Honorary president, sponsors, partners, donors and volunteers. With your support, the Foundation can pursue its mission to...